The Landscape of Expressed Chimeric Transcripts in the Blood of Severe COVID-19 Infected Patients

The ongoing COVID-19 pandemic caused by SARS-CoV-2 infections has quickly developed into a global public health threat. COVID-19 patients show distinct clinical features, and in some cases, during the severe stage of the condition, the disease severity leads to an acute respiratory disorder. In spit...

Full description

Bibliographic Details
Main Authors: Sunanda Biswas Mukherjee, Rajesh Detroja, Sumit Mukherjee, Milana Frenkel-Morgenstern
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/15/2/433
_version_ 1797617808349069312
author Sunanda Biswas Mukherjee
Rajesh Detroja
Sumit Mukherjee
Milana Frenkel-Morgenstern
author_facet Sunanda Biswas Mukherjee
Rajesh Detroja
Sumit Mukherjee
Milana Frenkel-Morgenstern
author_sort Sunanda Biswas Mukherjee
collection DOAJ
description The ongoing COVID-19 pandemic caused by SARS-CoV-2 infections has quickly developed into a global public health threat. COVID-19 patients show distinct clinical features, and in some cases, during the severe stage of the condition, the disease severity leads to an acute respiratory disorder. In spite of several pieces of research in this area, the molecular mechanisms behind the development of disease severity are still not clearly understood. Recent studies demonstrated that SARS-CoV-2 alters the host cell splicing and transcriptional response to overcome the host immune response that provides the virus with favorable conditions to replicate efficiently within the host cells. In several disease conditions, aberrant splicing could lead to the development of novel chimeric transcripts that could promote the functional alternations of the cell. As severe SARS-CoV-2 infection was reported to cause abnormal splicing in the infected cells, we could expect the generation and expression of novel chimeric transcripts. However, no study so far has attempted to check whether novel chimeric transcripts are expressed in severe SARS-CoV-2 infections. In this study, we analyzed several publicly available blood transcriptome datasets of severe COVID-19, mild COVID-19, other severe respiratory viral infected patients, and healthy individuals. We identified 424 severe COVID-19 -specific chimeric transcripts, 42 of which were recurrent. Further, we detected 189 chimeric transcripts common to severe COVID-19 and multiple severe respiratory viral infections. Pathway and gene enrichment analysis of the parental genes of these two subsets of chimeric transcripts reveals that these are potentially involved in immune-related processes, interferon signaling, and inflammatory responses, which signify their potential association with immune dysfunction leading to the development of disease severity. Our study provides the first detailed expression landscape of chimeric transcripts in severe COVID-19 and other severe respiratory viral infections.
first_indexed 2024-03-11T08:01:02Z
format Article
id doaj.art-b9d15be88d2641c2aabbb2abbd8e3e77
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-11T08:01:02Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-b9d15be88d2641c2aabbb2abbd8e3e772023-11-16T23:48:56ZengMDPI AGViruses1999-49152023-02-0115243310.3390/v15020433The Landscape of Expressed Chimeric Transcripts in the Blood of Severe COVID-19 Infected PatientsSunanda Biswas Mukherjee0Rajesh Detroja1Sumit Mukherjee2Milana Frenkel-Morgenstern3Cancer Genomics and BioComputing of Complex Diseases Lab, Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, IsraelCancer Genomics and BioComputing of Complex Diseases Lab, Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, IsraelCancer Genomics and BioComputing of Complex Diseases Lab, Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, IsraelCancer Genomics and BioComputing of Complex Diseases Lab, Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, IsraelThe ongoing COVID-19 pandemic caused by SARS-CoV-2 infections has quickly developed into a global public health threat. COVID-19 patients show distinct clinical features, and in some cases, during the severe stage of the condition, the disease severity leads to an acute respiratory disorder. In spite of several pieces of research in this area, the molecular mechanisms behind the development of disease severity are still not clearly understood. Recent studies demonstrated that SARS-CoV-2 alters the host cell splicing and transcriptional response to overcome the host immune response that provides the virus with favorable conditions to replicate efficiently within the host cells. In several disease conditions, aberrant splicing could lead to the development of novel chimeric transcripts that could promote the functional alternations of the cell. As severe SARS-CoV-2 infection was reported to cause abnormal splicing in the infected cells, we could expect the generation and expression of novel chimeric transcripts. However, no study so far has attempted to check whether novel chimeric transcripts are expressed in severe SARS-CoV-2 infections. In this study, we analyzed several publicly available blood transcriptome datasets of severe COVID-19, mild COVID-19, other severe respiratory viral infected patients, and healthy individuals. We identified 424 severe COVID-19 -specific chimeric transcripts, 42 of which were recurrent. Further, we detected 189 chimeric transcripts common to severe COVID-19 and multiple severe respiratory viral infections. Pathway and gene enrichment analysis of the parental genes of these two subsets of chimeric transcripts reveals that these are potentially involved in immune-related processes, interferon signaling, and inflammatory responses, which signify their potential association with immune dysfunction leading to the development of disease severity. Our study provides the first detailed expression landscape of chimeric transcripts in severe COVID-19 and other severe respiratory viral infections.https://www.mdpi.com/1999-4915/15/2/433chimeric transcriptssevere COVID-19aberrant splicingcis-SAGerespiratory viral infections
spellingShingle Sunanda Biswas Mukherjee
Rajesh Detroja
Sumit Mukherjee
Milana Frenkel-Morgenstern
The Landscape of Expressed Chimeric Transcripts in the Blood of Severe COVID-19 Infected Patients
Viruses
chimeric transcripts
severe COVID-19
aberrant splicing
cis-SAGe
respiratory viral infections
title The Landscape of Expressed Chimeric Transcripts in the Blood of Severe COVID-19 Infected Patients
title_full The Landscape of Expressed Chimeric Transcripts in the Blood of Severe COVID-19 Infected Patients
title_fullStr The Landscape of Expressed Chimeric Transcripts in the Blood of Severe COVID-19 Infected Patients
title_full_unstemmed The Landscape of Expressed Chimeric Transcripts in the Blood of Severe COVID-19 Infected Patients
title_short The Landscape of Expressed Chimeric Transcripts in the Blood of Severe COVID-19 Infected Patients
title_sort landscape of expressed chimeric transcripts in the blood of severe covid 19 infected patients
topic chimeric transcripts
severe COVID-19
aberrant splicing
cis-SAGe
respiratory viral infections
url https://www.mdpi.com/1999-4915/15/2/433
work_keys_str_mv AT sunandabiswasmukherjee thelandscapeofexpressedchimerictranscriptsinthebloodofseverecovid19infectedpatients
AT rajeshdetroja thelandscapeofexpressedchimerictranscriptsinthebloodofseverecovid19infectedpatients
AT sumitmukherjee thelandscapeofexpressedchimerictranscriptsinthebloodofseverecovid19infectedpatients
AT milanafrenkelmorgenstern thelandscapeofexpressedchimerictranscriptsinthebloodofseverecovid19infectedpatients
AT sunandabiswasmukherjee landscapeofexpressedchimerictranscriptsinthebloodofseverecovid19infectedpatients
AT rajeshdetroja landscapeofexpressedchimerictranscriptsinthebloodofseverecovid19infectedpatients
AT sumitmukherjee landscapeofexpressedchimerictranscriptsinthebloodofseverecovid19infectedpatients
AT milanafrenkelmorgenstern landscapeofexpressedchimerictranscriptsinthebloodofseverecovid19infectedpatients